spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Introducing the new Rapidox 7100

Dynascan


After receiving a fascia upgrade, the Rapidox 7100 will be easily identified with it’s new grey colour scheme and contemporary look.

The ideal partner for a multitude of industries, the Rapidox 7100 allows for six gases to be measured simultaneously which grants the user more flexibility than ever before. Fitted with high precision sensors, the Rapidox 7100 avoids any cross-interference effects with the background process gas.

Some of the measurable gases include: oxygen (O2), carbon monoxide (CO), carbon dioxide (CO2), ozone (O3), moisture (H2O), hydrogen (H2), hydrogen sulphide (H2S), nitric oxide (NO), nitrogen dioxide (NO2), nitrous oxide (N2O), sulphur dioxide (SO2), chlorine (Cl2), methane (CH4) and ethylene (C2H4).
The Rapidox 7100 is configurable to meet customer requirements. Bespoke sensor combinations, alternative mode options (permanent or sampling) and multi-language are some of the many options available. A number of features come as standard to provide the user with enhanced functionality such as:

• 7″ full-colour touchscreen with soft menu keys
• Continuous data logging with the ability to download data on to Excel via USB
• Operates on any worldwide mains voltage (90-260VAC 50/60Hz)
• Fully programmable alarm settings
• Password protection
• 19″ rack mountable enclosure

If you would like to learn more about the Rapidox 7100 Multigas Analyser, you can download the Technical Specification.
Cambridge Sensotec, the experts in gas analysis, would love to hear from you. If you require more details about the Rapidox 7100, or would like to discuss your requirements with one of our sales staff, please contact us using one of the methods below.
TEL: +44 (0)1480 462142
WEBSITE: Use our LiveChat function, found in the bottom right corner of your screen

phone +44 (0)1480 462142
email info@dynascan.co.uk
web www.dynascan.co.uk
email 29 Stephenson Road, St Ives, Cambridgeshire PE27 3WJ
 
Print this page
Send to a friend
   
spacer
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>


White Papers

Extractables and Leachables Testing: A Risk Based Approach

RSSL

Pharmaceutical products are in contact with many external components during both manufacture and usage and small amounts of chemicals may leach from these components with a potential health risk to the patient. Extractables and leachables (E&L) studies therefore play an important role in verifying the safety of a drug product over its lifetime. Regulatory organisations such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) are taking an increased interest in the interactions of various drug delivery devices, pharmaceutical product containers and medical devices with drug product and/or patient and this field is therefore growing in importance. Regulatory guidelines indicate that an extractables profile should be determined for all materials that contact the drug product. Once established, this profile can be used to determine whether any of these extractables are present as leachables within the product. If a leachable is detected, amounts can be determined using validated analytical methods, after which a biological risk can be established based on the exposure. This white paper will provide an overview of the processes used to determine extractables and leachables from plastics.
More info >>

Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement